Población de la concha de abanico (Argopecten purpuratus) en el área de Chimbote, del 16 al 24 de setiembre 1999

Presenta los resultados de la evaluación poblacional de concha de abanico en Chimbote, efectuada entre el 16 y 24 de setiembre de 1999, cubriendo las áreas de Isla Santa, Isla Blanca, Hueco de la Vela, bahía de Samanco y Los Chimus, de donce se concluye que la disponibilidad del recurso fue pobre en las áreas.

Tohtori Johannes Virolainen 16/5 1970

Kirje 16.5.1970

Carte générale et détaillée de la Bretagne représentant en grande partie la région occidentale de la France comprise dans 16 départements entiers ou partiels : avec les distances précises entre les principaux endroits / dessiné et gravé par E Collin

Échelle(s) : [ca 1:710 000], échelle de 10 myriamètres [= 14,1 cm]

Herra Erkki Haaksluoto 16/2 1970

Kirje 16.2.1970

'The Advocate' Resident Advocate Newsletter, January 2009, Vol. 16

This tool of communication between the 2,500 members of the Resident Advocate Committee (RAC) Program and the State Long-Term Care Ombudsman is used to keep all volunteers informed of their roles and responsibilities as they carry out the duties of a resident advocate. The Advocate is provided to Resident Advocates on a quarterly basis.

Motor Vehicle Crash Fatalities for Week Ending, January 16, 2008

Motor Vehicle Crash Fatalities

Selectividad con red chinchorro con dos diferentes tipos de copo en la Isla San Lorenzo, Callao. 16 al 20 de febrero 1998

Presenta información sobre el trabajo realizado con la finalidad de medir la respuesta selectiva, eficiencia y comportamiento del arte de pesca con red chinchorro, dicha experiencia se realizó entre el 16 y el 20 de febrero de 1998.

EPI Update, January 16, 2009

Weekly newsletter for Center For Acute Disease Epidemiology of Iowa Department of Public Health.

EPI Update, January 16, 2009

Weekly newsletter for Center For Acute Disease Epidemiology of Iowa Department of Public Health.

Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study.

OBJECTIVES: To provide a global, up-to-date picture of the prevalence, treatment, and outcomes of Candida bloodstream infections in intensive care unit patients and compare Candida with bacterial bloodstream infection. DESIGN: A retrospective analysis of the Extended Prevalence of Infection in the ICU Study (EPIC II). Demographic, physiological, infection-related and therapeutic data were collected. Patients were grouped as having Candida, Gram-positive, Gram-negative, and combined Candida/bacterial bloodstream infection. Outcome data were assessed at intensive care unit and hospital discharge. SETTING: EPIC II included 1265 intensive care units in 76 countries. PATIENTS: Patients in participating intensive care units on study day. INTERVENTIONS: None. MEASUREMENT AND MAIN RESULTS: Of the 14,414 patients in EPIC II, 99 patients had Candida bloodstream infections for a prevalence of 6.9 per 1000 patients. Sixty-one patients had candidemia alone and 38 patients had combined bloodstream infections. Candida albicans (n = 70) was the predominant species. Primary therapy included monotherapy with fluconazole (n = 39), caspofungin (n = 16), and a polyene-based product (n = 12). Combination therapy was infrequently used (n = 10). Compared with patients with Gram-positive (n = 420) and Gram-negative (n = 264) bloodstream infections, patients with candidemia were more likely to have solid tumors (p < .05) and appeared to have been in an intensive care unit longer (14 days [range, 5-25 days], 8 days [range, 3-20 days], and 10 days [range, 2-23 days], respectively), but this difference was not statistically significant. Severity of illness and organ dysfunction scores were similar between groups. Patients with Candida bloodstream infections, compared with patients with Gram-positive and Gram-negative bloodstream infections, had the greatest crude intensive care unit mortality rates (42.6%, 25.3%, and 29.1%, respectively) and longer intensive care unit lengths of stay (median [interquartile range]) (33 days [18-44], 20 days [9-43], and 21 days [8-46], respectively); however, these differences were not statistically significant. CONCLUSION: Candidemia remains a significant problem in intensive care units patients. In the EPIC II population, Candida albicans was the most common organism and fluconazole remained the predominant antifungal agent used. Candida bloodstream infections are associated with high intensive care unit and hospital mortality rates and resource use.